Geneix Company

Geneix was founded on the belief that smart data, coupled with smart design, can play a significant role in providing solutions which meet the ever growing need and demand for new solutions which improve patient care, reduce costs and increase efficiency.
Geneix's first digital solution, InterAct, is an e-prescribing platform that uses big data to help lower the potential of drug to drug interactions. By using a simple application a healthcare professional can retrieve a patient's electronic medical health records, select a treatment they would like to prescribe and receive an instantaneous warning if the suggested prescription will interact with any current treatments. InterAct not only warns healthcare professionals of any potential interactions at the point of prescription, it also offers alternatives with few or no known interactions.

Investors
Technology: Machine Learning
Industry: Healthcare
Headquarters: London, England, United Kingdom
Founded Date: 2011
Employees Number: 1-10
Funding Status: Seed

Visit Website
mark@geneix.com
@GeneixLTD
Register and Claim Ownership